Dr. Jeffrey Borer has been an adjunct professor and attending physician of cardiovascular medicine in cardiothoracic surgery at Weill Cornell Medicine since 2008. After more than 30 years of gaining an international reputation as a Fulbright Scholar in England, an investigator for the National Institutes of Health and as a researcher and clinical practitioner at Cornell Medical Center, Dr. Borer returned to his Brooklyn roots. “It was time for me to give back to the community that gave so much to me,” he said upon making this decision. His most recent investigations center on the cellular and molecular bases of heart failure in regurgitant valvular diseases, and a novel therapy to prevent cardiac fibrosis.

In recognition of his work throughout his career, Dr. Borer has been named among the top one percent of physicians by the United States News and World Report L.P. He is a patentee in the field for being a co-inventor of a method for inhibiting fibroblast growth and cardiac fibrosis. Dr. Borer has been nationally and internationally acclaimed for his work in establishing the benefits of nitroglycerin during heart attacks and its application during exercise, allowing doctors for the first time to see heart abnormalities directly as they occur during exercise. This profoundly changed the way diagnosis and prognostication occur in cardiology.

In addition to his position at Weill Cornell, Dr. Borer also currently serves as a professor of public health, surgery, radiology and cell biology at SUNY Downstate Medical Center, and as a professor in the Department of Academic Orthopedic Surgery at the New York College of Podiatric Medicine. He has been the Chairman of the Cardiovascular Devices Subcommittee of the International Standardization Organization since 2016, and a Fellow of the International Academy of Cardiovascular Sciences since 2011.

On a civic level, Dr. Borer he has served as the Chairman of the Committee on Restoration and as the Chairman of the Building Preservation Committee at the Brooklyn Jewish Center since 2009. In 1999, he joined The Glorney Foundation as a trustee and has served as the president of the board of trustees since 2000.

Earlier in his career, Dr. Borer garnered experience in a variety of roles with many esteemed institutions. These include the National Heart, Lung, and Blood Institute, the Clinical Electrophysiology Laboratory, the National Institutes of Health, the National Heart and Lung Institute, NASA and the United States Food and Drug Administration among many others. His international acclaim has extended to being a visiting professor of the Chinese Academy of Medical Sciences with the Peking Union Medical College and being an honorary fellow of the Argentine Heart Association.

In recognition of his more than four decades of medical service, Dr. Borer has received a number of awards and accolades. In 2018, he received the Kanu Chatterjee Lifetime Achievement Award for Contributions to Cardiovascular Medicine. He has also received the Award for Lifetime Achievement in Heart Valve Diseases from The Heart Valve Society International and Society for Heart Valve Diseases and the Legend of Cardiology Award during the 10^th Annual Global Summit. Furthermore, he has received: Transforming Lives through Research Award, SUNY Downstate Medical Center in 2009; the FDA Service Award in 2004; the Hans-Peter Krayenbuehl Memorial Award from the International Academy of Cardiology in 2002; a Public Service Medal from NASA in 1999; the Pfizer Visiting Professorship in Cardiovascular Medicine Award in 1999; the Student Scholar in Cardiovascular Disease and Stroke Award Preceptor from the American Heart Association, Inc. in 1997; a Special Citation for Outstanding and Sustained Contribution to Furtherance of the NASA Mission in 1997; a Special Citation for Sustained Contributions to the NASA-Mir Mission in 1997; a Certificate of Appreciation for Performance as Member of Federal Laboratory Review Committee in Response to Presidential Review Directive NSTC- from NASA in 1995; a Distinguished Visiting Scientist, Pig Research Institute of Taiwan from the Cardiovascular Institute in 1994; the Castle Connolly Top Doctor in Cardiovascular Disease recognition from New York Magazine  between 1993 and 2016; a Certificate of Appreciation for Contributions to Aerospace Medicine Advisory Committee from NASA in 1993; a Special Award for Outstanding Contribution to the Cause of Preventive Cardiology in Israel from the Israel National Heart to Heart Association in 1992; and a Citation for Outstanding Services in the Fields of Cardiology and Open Heart Surgery from the World Conference on Open Heart Surgery in Bombay, India in 1985.

Dr. Borer knew in high school that he wanted to go into the field of medicine. He first earned a Bachelor of Arts in government from Harvard College, cum laude, in 1965 and continued at Cornell University to receive an MD in 1969. He interned, completed residencies and a clinical fellowship at the General Hospital Corporation and Harvard University. He served as a chief Resident Physician for the National Heart, Lung and Blood Institute with the National Institutes of Health and was a Senior Fulbright-Hays Scholar in the Cardiac Department at Guy’s Hospital with the University of London. Furthermore, he was a Glorney-Raisbeck Fellow in the Medical Sciences with the New York Academy of Medicine. In 1969, Dr. Borer was one of 20 students from American medical schools selected as first student representatives to the Annual Meeting of the Association of American Medical Colleges. Throughout the 1970s, Dr. Borer was a surgeon with the US Public Health Service.